Google+ Facebook Twitter Twitter

Tech news: October

This month's top tech news stories

Diagnostic contract

Irish Deputy Prime Minister Leo Varadkar has welcomed a five-year contract secured by Irish laboratory diagnostics specialists, Serosep, with Liverpool University Hospital NHS Foundation Trust.

He did so during a UK trade mission organised by Enterprise Ireland. The contract is to supply their innovative molecular diagnostic solution, EntericBio, used to diagnose gastroenteritis.

Nanofibre Devices

A global leader in nanofibre-based medical devices has changed its name from IME Medical Electrospinning to Vivolta.

The new name reflects the evolution to being a full-service ISO 13485-certified MedTech company for nanofibre-based medical devices, tissue engineering and drug delivery solutions.

Judith Heikoop, Chief Executive Officer, said: “Our new name completes this transformation and supports our exciting new vision.”



New research facility

Diagnosing, treating and curing disease is the mission of scientists working in a new £100m research institute that has officially opened at the University of Nottingham.

The University’s Biodiscovery Institute is a world-leading hub of interdisciplinary research, tackling everything from defeating cancer to sustainable transport, regenerative medicine and the Black Death.

The institute offers state-of-the-art laboratories, research equipment and facilities and is home to approximately 850 researchers, clinicians and staff.


Image credit | University-of-Nottingham| Serosep |Shutterstock

Related Articles

Under the microscope: chronic allograft dysfunction

What is chronic allograft dysfunction (CLAD)?

A range of pathologies that cause a transplanted lung to not achieve or maintain normal function. CLAD manifests as airflow restriction or obstruction.

Evolutionary changes in brain development

More than 3000 regions in the human genome are very different to those in the genome of any other mammals, including our closest primate relatives.

Turning normal cells into cancer cells

There is new evidence that normal human fibroblast cells can be converted to specific cancer cells using only factors that are commonly detected in actual human patients.

One fat cell subtype responds to insulin stimulation

Scientists have discovered that there are three different subtypes of mature fat cells in white adipose tissue and that it is only one of these – AdipoPLIN – that responds to insulin.